EDWARD W. WITHROW III - 31 Dec 2021 Form 5 Insider Report for PARALLAX HEALTH SCIENCES, INC. (PRLX)

Role
10%+ Owner
Signature
EDWARD W. WITHROW III
Issuer symbol
PRLX
Transactions as of
31 Dec 2021
Transactions value $
$99,932
Form type
5
Filing time
17 Mar 2022, 17:15:39 UTC
Previous filing
04 Mar 2022
Next filing
17 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRLX PREFERRED STOCK (SERIES A) Other $99.9K +36.3K +10% $2.75 400K 30 Sep 2011 By Huntington Chase Financial Group F1
transaction PRLX PREFERRED STOCK (SERIES A) Other $0 +396K +99.15% $0.00 796K 06 Nov 2021 By Huntington Chase Financial Group F2
transaction PRLX PREFERRED STOCK (SERIES A) Other $0 -796K -100% $0.00* 0 06 Nov 2021 By Huntington Chase Financial Group F3
transaction PRLX COMMON STOCK Other $0 +15.9M +28.17% $0.00 72.4M 06 Nov 2021 By Huntington Chase LLC F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PRLX STOCK OPTION Disposed to Issuer $0 -3M -75% $0.00 1M 31 Mar 2021 COMMON STOCK 3M $0.25 By Huntington Chase LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Additional Series A Preferred shares acquired; not included in previous Form 5 for the year 12/31/2012. Total Series A Preferred shares held at 12/31/12 = 399,732.
F2 Cumulative dividends in kind on Series A Preferred Stock.
F3 Conversion of preferred stock into common stock at a ratio of 20 shares of common stock for each share of preferred stock.
F4 Unvested stock options canceled upon resignation of Reporting Person.